Intra-cellular Therapies, Inc. Earnings logo

ITCI

Intra-cellular Therapies, Inc. Earnings

$83.45

Earnings Summary

Revenue
$175.16Mn
Net Profits
$-26.32Mn
Net Profit Margins
-15.03%
Highlights
Revenue:

Intra-cellular Therapies, Inc.’s revenue jumped 39.23% since last year same period to $175.16Mn in the Q3 2024. On a quarterly growth basis, Intra-cellular Therapies, Inc. has generated 8.53% jump in its revenue since last 3-months.

Net Profits:

Intra-cellular Therapies, Inc.’s net profit fell -8.52% since last year same period to $-26.32Mn in the Q3 2024. On a quarterly growth basis, Intra-cellular Therapies, Inc. has generated -62.29% fall in its net profits since last 3-months.

Net Profit Margins:

Intra-cellular Therapies, Inc.’s net profit margin jumped 22.06% since last year same period to -15.03% in the Q3 2024. On a quarterly growth basis, Intra-cellular Therapies, Inc. has generated -49.53% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Intra-cellular Therapies, Inc. post its latest quarter earnings
EPS Estimate Current Year
-0.32
Highlights
EPS Estimate Current Year:

Intra-cellular Therapies, Inc.’s earning per share (EPS) estimates for the current year stand at -0.32.

Key Ratios

Key ratios of the Intra-cellular Therapies, Inc. post its Q3 2024 earnings
Earning Per Share (EPS)
-0.25
Highlights
Earning Per Share (EPS):

Intra-cellular Therapies, Inc.’s earning per share (EPS) jumped 0% since last year same period to -0.25 in the Q3 2024. This indicates that the Intra-cellular Therapies, Inc. has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-10-30
-0.2
-0.25
-25%
2024-05-07
-0.32
-0.16
50%
2024-08-07
-0.19
-0.16
15.79%